This conference focuses on economic aspects of diabetes and its complications.
A major focal point of the conference will be a comparison of health economic diabetes models both in terms of their structure and performance. This conference builds on six previous diabetes simulation modelling conferences that have been held since 1999. A write-up of a past conference can found by here.
A particular theme of the 2014 challenge will be how to generalise diabetes simulation models for different populations and over time. To what degree are existing models able to adjust for differences risk due to ethnic and socio-economic differences as well as any secular improvements in diabetes care?"
The conference will also have open sessions on all aspects of the health economics of diabetes.
Following previous Mount Hood Challenges, the emphasis will be on comparing model projections to real world or clinical trial outcomes, and explanation and discussion of differences seen between each model and the real world results.
Abstract submissions are invited on the following themes
(1) Modelling diabetes disease progression and its complications
(2) Effect of diabetes on society – its impact on life and work
(3) Economic approaches to measuring quality of life
(4) Quantifying the cost of diabetes and its complications
(5) Methodological aspects of diabetes modelling
Abstract Submission Requirements
ALL ABSTRACTS ARE TO BE SUBMITTED via email firstname.lastname@example.org
SUBMISSION DEADLINE: Friday 28th March 2014
ALL ABSTRACT SUBMISSIONS AND PRESENTATIONS MUST BE IN ENGLISH.
Conference registration is required for all presenters. Note if the abstract is not accepted for presentation, participants that have registered can withdraw from the conference prior to end of April 2014 without financial penalty.
The presenters of research are required to disclose financial support. Abstract review will NOT be based on this information.
The research abstracts, EXCLUDING title and author information, should be no longer than 300 words.
The use of tables, graphs and figures in your research abstract submission are not allowed.
Generic names should be used for technologies (drugs, devices), not trade names.
Research that has been published at any national or international meeting prior to this Conference is discouraged.
MULTIPLE ABSTRACTS ON THE SAME STUDY ARE DISCOURAGED.
Abstracts will be reviewed by the steering committee and notification of acceptance or rejection will be made by 15th April 2014